MONJUVI

Indicated For

relapsed or refractory diffuse large B-cell lymphoma

About This Medication

# IncyteCARES for MONJUVI Patient Assistance Program Patient Guide: How to Get MONJUVI (tafasitamab-cxix) at Low or No Cost MONJUVI (tafasitamab-cxix) is a prescription medication used to treat certain types of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in adults after at least two prior therapies. The **IncyteCARES for MONJUVI Patient Assistance Program (PAP)**, offered by Incyte, provides free medication to eligible uninsured or underinsured patients who meet specific financial and residency criteria.[1][2][3] ## About MONJUVI and Why Assistance Matters **MONJUVI** is a targeted immunotherapy (a monoclonal antibody) combined with lenalidomide for treating DLBCL, a type of non-Hodgkin lymphoma. It's given as an intravenous infusion, typically in cycles over several weeks. Treatment costs can exceed tens of thousands of dollars per cycle without coverage, making programs like IncyteCARES essential for access.[1][3] The PAP covers the **cost of the medication only**—not infusion or administration fees at your doctor's office or clinic. It's designed for patients facing high out-of-pocket expenses or no coverage.[2][3][5] ## Who Qualifies for the Program? To enroll, you must first join **IncyteCARES for MONJUVI**, a free support service that assesses insurance and connects you to assistance options. Then, for the PAP specifically:[3] - Be a resident of the **United States or Puerto Rico**.[2][3] - Have a **valid prescription** for MONJUVI for an FDA-approved use (e.g., relapsed/refractory DLBCL after two prior lines).[3] - Be **uninsured** (no medical coverage) **or underinsured** (insurance denies coverage for MONJUVI, exhausts benefits, or leaves unaffordable costs).[3] - **Meet household income criteria** (needs-based; exact thresholds not publicly listed—Incyte assesses case-by-case).[2][3] - For Medicare Part B patients: Coverage must be **exhausted or denied**, and no Medigap supplemental insurance.[3] **Important exclusions**: Patients with government insurance like Medicare (without denial), Medicaid, TRICARE, or state programs may not qualify for PAP but could access other IncyteCARES support.[3] ## Income Eligibility Breakdown The program is **needs-based**, requiring proof of household income. Specific Federal Poverty Level (FPL) percentages or dollar thresholds (e.g., for 1-person, 2-person households) are **not publicly detailed**—Incyte evaluates individually during enrollment. Call 1-855-452-5234 for a pre-screening.[2][3] Here's a general overview based on similar programs (consult Incyte for your situation): | Household Size | Typical Threshold Example (e.g., 400-500% FPL)* | Notes | |---------------|------------------------------------------------|-------| | 1 Person | ~$60,000–$75,000 annually | Exact amount varies; proof required[3] | | 2 People | ~$80,000–$100,000 annually | Household income only[3] | | 3 People | ~$100,000–$125,000 annually | Includes all residents[3] | | 4+ People | Scales up accordingly | Contact for details[2] | *Estimates for illustration; **not official**. Program may change. Always verify with IncyteCARES.[3] ## Insurance Requirements - **Commercial insurance required for initial IncyteCARES enrollment**.[3] - PAP targets **uninsured** (no coverage) or **underinsured** (denied/exhausted commercial coverage, Medicare Part B denied without Medigap).[1][2][3] - Government programs (Medicare, Medicaid) often ineligible for PAP; explore IncyteCARES savings options or independent foundations instead.[3] - Provide **proof of insurance status or denial letter** from your plan.[3] ## Step-by-Step Application Process 1. **Get a prescription**: Ask your oncologist/hematologist for MONJUVI.[3] 2. **Enroll in IncyteCARES**: Your doctor downloads the enrollment form from hcp.incytecares.com, completes it (patient info, insurance, optional income), and faxes to **1-866-870-6241**. Takes ~15 minutes.[3][4] 3. **IncyteCARES contact**: Within **3 business days**, a representative calls you to review coverage, assess PAP eligibility, and collect any missing info (e.g., income).[3][4] 4. **Submit documents**: Fax or provide via phone: - Valid MONJUVI prescription - Proof of income (e.g., tax returns, pay stubs, W-2s for household) - Proof of residency (e.g., utility bill, driver's license) - Proof of insurance/denial[3][4] 5. **Approval notification**: If approved, medication ships free to your **physician's office**.[2] Call **1-855-452-5234** (M-F, 8 AM–8 PM ET) for help anytime.[1][2] ## Timeline and Delivery - **Processing**: IncyteCARES contacts within 3 business days; full approval varies (typically 1-2 weeks, but call for updates).[4] - **Delivery**: Free shipment to doctor's office; your provider handles infusion scheduling.[2] - **Reauthorization**: **Required**—submit updated docs periodically (e.g., annually or per cycle).[3] - **Duration**: Covers treatment as long as eligible; annual benefit maximum may apply.[5] ## Alternatives if Denied - **IncyteCARES Savings Program**: For commercial insurance (min $15.01 OOP cost; annual max).[3][5] - **Independent foundations**: IncyteCARES can refer to orgs helping with meds, travel, lodging.[3] - **Other PAPs**: Check PAN Foundation, Patient Access Network, or NeedyMeds. - **State programs**: Varies by location. - **Appeal**: Contact IncyteCARES to discuss denial reasons and resubmit.[3] No biosimilar alternatives to MONJUVI are currently available.[3] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2024. **Program terms can change** (e.g., May 1, 2024 update).[3][5] Eligibility not guaranteed. **Consult your doctor and call IncyteCARES at 1-855-452-5234** for personalized advice. Does not cover administration costs. IncyteCARES.com/MONJUVI for latest details. Not affiliated with government programs.

Program information last verified: March 25, 2026